Investment Verdict
SNPS is a high-quality growth asset, but the current setup is watchlist rather than actionable. The business has durable demand from artificial intelligence chip complexity, 3D integrated circuits, advanced nodes, hardware-assisted verification, design IP, and Ansys multiphysics simulation. The issue is not business quality. It is valuation, integration debt, and the need to prove that Ansys synergies and new monetization models can lift organic growth rather than only add acquisition revenue. S1 S2
Decision Hinge
The hinge is whether Synopsys can turn the Ansys combination into higher organic growth and margin expansion without damaging the core EDA franchise. Upside requires clean integration, visible fiscal 2027 revenue synergies, IP recovery, and credible pricing for agentic EDA and Multiphysics Fusion. The view weakens if growth is mostly acquisition math, China remains pressured, or the balance sheet constrains buybacks and flexibility.
Executive Answer
What Matters
Q2 FY2026 revenue rose +41.9% to $2.3B, but non-GAAP earnings per share declined -8.7% year-over-year. Quality is still high, but integration and debt now matter. S2
Why Now
Synopsys completed Ansys on July 17, 2025, creating a broader silicon-to-systems platform. Q2 FY2026 is the first clean look at the combined portfolio with raised guidance and visible synergy expectations. S5
What Changes The View
The report moves from watchlist to attractive for deeper work if fiscal 2027 estimates show organic acceleration, IP reaccelerates, and non-GAAP operating margins move toward the mid-40s without relying mainly on add-backs.
Fundamentals Snapshot
| Metric | Current Read | Source / Interpretation |
|---|---|---|
| Share price | $456.39 | Yahoo Finance chart endpoint observed 2026-06-18 19:42:45 UTC. S8 |
| Market value | $87.4B live quote / $88.4B Fiscal.ai | Live value uses 191.4M shares. Fiscal.ai market data was pulled earlier in the day. S1 S8 |
| Enterprise value | $95.7B price-adjusted / $96.8B Fiscal.ai | Price-adjusted value uses $10.8B debt and $2.5B cash plus short-term investments. S1 |
| Latest reported quarter | FY2026 Q2 ended April 30, 2026 | Revenue $2.3B, non-GAAP EPS $3.35, and free cash flow $574.7M. S2 S3 |
| Balance sheet | $2.5B cash and investments, $10.8B debt, $8.4B net debt | The Ansys acquisition shifted Synopsys from net cash to a leveraged but still manageable software balance sheet. {cite('S1')} |
| Valuation | 32.1x next-twelve-month price-to-earnings, 11.3x EV/sales | Also 25.5x next-twelve-month enterprise-value-to-EBITDA and 50.7x price-to-free-cash-flow. S1 |
| Consensus price-target context | Mean $559.58; median $575.00 | 24 estimates, low $404, high $650. This is context, not this report's target price. S1 |
All financial figures are in United States dollars. Source currency is United States dollars; no exchange rate conversion or converted financial figures were required.
Growth-Investment Scorecard
| Factor | Score / 5 | Evidence |
|---|---|---|
| Revenue growth | 5 | Q2 revenue rose +41.9% year-over-year, helped by Ansys; consensus expects +37.4% fiscal 2026 revenue growth. S1 S2 |
| Earnings growth | 3 | Non-GAAP EPS fell -8.7% in Q2 because integration, mix, and interest burden dilute reported earnings quality; consensus still expects +15.3% fiscal 2026 EPS growth. S1 S2 |
| Durability | 5 | Remaining performance obligations were $11.0B and recurring revenue was 83% of Q2 revenue. S1 S2 |
| Margin quality | 3 | Non-GAAP operating margin was 39.5%, but GAAP operating margin was only 10.4% because acquisition amortization and restructuring are large. S2 S3 |
| Cash generation | 4 | Q2 free cash flow was about $574.7M and management raised FY2026 free-cash-flow guidance to about $2.0B. S2 |
| Balance sheet | 3 | Net debt is about $8.4B after Ansys; manageable, but interest expense now matters to equity returns. S1 S6 |
| Valuation | 2 | At 32.1x next-twelve-month earnings and 11.3x next-twelve-month sales, the stock needs durable double-digit growth and synergy execution. S1 |
| Competitive position | 5 | Synopsys has top-tier EDA, IP, verification, and now Ansys multiphysics assets, but Cadence remains a strong direct competitor. {cite('S4')} {cite('S5')} |
| Market timing | 3 | Artificial intelligence chip complexity is a real demand driver, but the share price already reflects a large part of the quality and integration story. |
What The Company Does
Synopsys sells electronic design automation software, semiconductor intellectual property, hardware-assisted verification systems, manufacturing and sign-off tools, and now Ansys simulation and analysis products. Customers use these tools to design chips, verify that designs work, model physical behavior, and connect chip-level design with system-level engineering. S2 S4
The business model is software-heavy and recurring. It monetizes multi-year software subscriptions, time-based licenses, upfront hardware and IP transactions, and maintenance or services. The strategic shift after Ansys is broader: Synopsys wants to be the engineering platform from silicon to full physical systems. S2 S5
Segment Mix
| Segment | Q2 revenue | Growth | Adjusted margin | Role |
|---|---|---|---|---|
| Design Automation | $1.8B | +62.3% | +43.3% | Core EDA, verification, system integration, manufacturing software, and Ansys products. This is the largest and most strategic segment. |
| Design IP | $454.2M | -5.8% | +24.4% | Logic libraries, embedded memories, interface IP, security IP, and processor IP. Near-term growth is muted as the company refocuses on higher-value AI and hyperscaler opportunities. |
Market Fit
Synopsys fits the current market because artificial intelligence increases chip complexity, architectural diversity, advanced packaging, verification needs, and thermal/power constraints. Management specifically pointed to AI-driven design activity, advanced-node and 3D integrated circuit demand, hardware-assisted verification demand from hyperscalers, agentic design automation, and Multiphysics Fusion as current growth vectors. S4
The market-fit problem is expectations. A premium software multiple is reasonable for high durability, but SNPS now also carries acquisition leverage, restructuring, integration complexity, and China/export-control exposure. That combination requires more evidence than a normal high-quality EDA compounder.
Q2 Geographic Mix
| Region | Q2 revenue | Mix |
|---|---|---|
| United States | $974.4M | 42.8% |
| Europe | $378.1M | 16.6% |
| China | $240.4M | 10.6% |
| Korea | $265.4M | 11.7% |
Good Growth Investment: Yes If / No If / Watch Next
Yes If
- Fiscal 2027 starts to show real Ansys revenue synergy, not only acquired revenue and accounting changes.
- Design IP sequential recovery continues and the new hyperscaler/custom-silicon business model becomes visible in orders.
- Non-GAAP operating margin moves toward the mid-40s while GAAP quality improves as integration charges normalize.
- China and export-control pressure stays manageable, and EDA renewals remain strong.
No If
- Ansys growth decelerates after the acquisition-year comparison normalizes.
- Multiphysics Fusion remains in evaluation and does not become priced revenue in fiscal 2027.
- Debt, interest expense, or restructuring consume more of the earnings story than expected.
- Cadence gains share in core EDA or valuation spreads keep favoring the cleaner comp.
Long-Term Growth Expectations And Growth Products
Management's combined-company objectives are industry-leading double-digit revenue growth, double-digit Design Automation growth, mid-teens Design IP growth, long-term non-GAAP operating margin in the mid-40s, unlevered free-cash-flow margin in the mid-30s, and high-teens non-GAAP earnings-per-share growth. These are company objectives, not verified outcomes. S4
The growth products are core EDA design and sign-off, hardware-assisted verification platforms such as ZeBu and HAPS, 3DIC Compiler, Design IP for PCIe 7.0, 224G connectivity, UCIe and HBM4, GPU-accelerated EDA, agentic EDA workflows, and Ansys-linked Multiphysics Fusion. S4
Main Growth Question
Multiphysics Fusion is the most important new-product question. Management says commercial availability starts in the second half of fiscal 2026 and revenue synergy begins in fiscal 2027. The report needs future evidence that customers pay incremental dollars for the combined workflow. S4
Ten-Quarter Revenue And Earnings Charts
Ten-quarter view: last six reported quarters, one company-guided quarter, and next three quarters from analyst estimates. Revenue is in billions of United States dollars. Earnings are non-GAAP diluted earnings per share. Labels show year-over-year growth rates.
| Quarter | Status | Revenue | Revenue year-over-year | Earnings per share | EPS year-over-year | Basis |
|---|---|---|---|---|---|---|
| FY25 Q1 | Reported | $1.5B | -3.7% | $3.03 | -14.9% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY25 Q2 | Reported | $1.6B | +10.3% | $3.67 | +22.3% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY25 Q3 | Reported | $1.7B | +14.0% | $3.39 | -1.2% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY25 Q4 | Reported | $2.3B | +37.8% | $2.90 | -14.7% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY26 Q1 | Reported | $2.4B | +65.5% | $3.77 | +24.4% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY26 Q2 | Reported | $2.3B | +41.9% | $3.35 | -8.7% | Reported revenue and Fiscal.ai non-GAAP EPS history by fiscal period-end date |
| FY26 Q3 guide | Company guide | $2.4B | +40.0% | $3.66 | +8.0% | Company midpoint of Q3 FY2026 revenue and non-GAAP EPS guidance |
| FY26 Q4 est. | Analyst estimate | $2.6B | +13.2% | $4.00 | +37.8% | Fiscal.ai consensus mean estimate |
| FY27 Q1 est. | Analyst estimate | $2.6B | +9.8% | $4.30 | +14.1% | Fiscal.ai consensus mean estimate |
| FY27 Q2 est. | Analyst estimate | $2.5B | +11.2% | $3.89 | +16.0% | Fiscal.ai consensus mean estimate |
Growth Estimates Consensus
Three-year projection chart from Fiscal.ai consensus mean estimates. These are market-data estimates, not this report's forecasts. 2025 is included as the base year for growth math.
| Year | Revenue | Revenue growth | Earnings per share | EPS growth | Estimate count |
|---|---|---|---|---|---|
| 2025A | $7.0B | base | $12.83 | base | 25 revenue / 23 EPS |
| 2026E | $9.7B | +37.4% | $14.79 | +15.3% | 23 revenue / 21 EPS |
| 2027E | $10.7B | +10.8% | $17.25 | +16.6% | 23 revenue / 23 EPS |
| 2028E | $12.0B | +12.0% | $20.41 | +18.3% | 13 revenue / 14 EPS |
Competitive Comparison
Cadence is the closest public comp for core EDA. Dassault, Siemens, Autodesk, and Keysight are less direct but help frame design, simulation, industrial software, and validation tool-chain economics. Legacy Ansys is now inside Synopsys, so it is no longer a clean public peer.
| Ticker | Product position | 3-year revenue CAGR | Forward 2-year revenue CAGR | Forward 2-year EPS CAGR | EBITDA margin | NTM P/E | NTM EV/Sales | NTM EV/EBITDA | Peer read-through |
|---|---|---|---|---|---|---|---|---|---|
| SNPS - Synopsys | EDA, design IP, verification hardware, and Ansys multiphysics simulation | +20.0% | +23.3% | -12.8% | +19.5% | 32.1x | 11.3x | 25.5x | Subject company; now includes Ansys, so near-term growth has acquisition and accounting noise. |
| CDNS - Cadence Design Systems | Closest public EDA peer across design, verification, IP, and system design | +14.5% | +15.2% | +19.3% | +36.4% | 47.0x | 16.9x | 35.7x | Best public comp for core EDA quality; valuation is higher and cleaner because it has less integration debt. |
| ADSK - Autodesk | Engineering and design software for architecture, manufacturing, media, and construction | +13.7% | +12.2% | +35.9% | +28.5% | 19.0x | 6.1x | 14.9x | Less direct EDA comp; useful software valuation benchmark with strong free cash flow. |
| DSY - Dassault Systemes | 3D design, product lifecycle, simulation-adjacent industrial software | +2.2% | +3.5% | +7.9% | +27.1% | 12.5x | 3.1x | 8.5x | More industrial software and life sciences than EDA; growth and valuation are materially lower. |
| SIE - Siemens | Broad industrial conglomerate with Siemens EDA and industrial software assets | +2.2% | +6.3% | -0.7% | +14.9% | 22.3x | 3.1x | 16.1x | EDA exposure is embedded inside a much broader industrial base, so public multiples are not pure. |
| KEYS - Keysight Technologies | Electronic test, measurement, design validation, and regulatory-required merger divestiture assets | +2.9% | +19.4% | +23.1% | +23.5% | 36.6x | 8.8x | 30.0x | Adjacent tool-chain peer, not a direct software comp; useful for validation and hardware-assisted design read-through. |
Valuation And Decision Hinge
At the live price, SNPS trades at about 30.9x fiscal 2026 consensus earnings per share, 26.5x fiscal 2027, and 22.4x fiscal 2028. On a price-adjusted enterprise value basis, it trades near 8.9x fiscal 2027 revenue and 8.0x fiscal 2028 revenue. S1 S8
The right valuation method today is peer-relative software multiples with a separate integration bridge. A formal target price would be premature without a segment model for organic EDA, Design IP, Ansys growth, synergy timing, debt paydown, restructuring costs, and free cash flow.
A simple downside mechanism is multiple compression toward lower-growth software comps if the market decides Ansys added scale but not faster organic growth. The upside mechanism is Cadence-like or better quality with a larger addressable market, higher pricing, and fiscal 2027 synergy evidence.
What Must Be True
- Core EDA remains a mission-critical oligopoly with sustained pricing power.
- Ansys expands Synopsys from chip design into system-level engineering without diluting focus.
- Design IP moves from weak 2026 growth to mid-teens growth over time.
- Adjusted margin targets convert into cash, not only accounting exclusions.
Thesis, Disconfirmers, Catalysts, And Monitoring Items
Thesis
- Synopsys owns hard-to-replace design tools in a market where chip complexity keeps rising.
- Ansys gives the company a credible silicon-to-systems platform at the exact moment AI systems need thermal, fluid, power, and structural simulation.
- Agentic EDA and consumption-based usage could expand the revenue model if customers adopt tool-running agents at scale.
Disconfirming Evidence
- Q2 GAAP earnings per share were only $0.09, far below non-GAAP EPS, because acquisition-related charges are heavy. S2
- Design IP revenue declined -5.8% year-over-year in Q2, so one of the long-term growth engines still needs proof. S1
- China export controls and design-start weakness remain explicit risks. S7
- Net debt is now meaningful after Ansys, raising the threshold for capital allocation and earnings quality. S1
Catalysts
- Q3 FY2026 results versus the $2.4B revenue guide and $3.66 non-GAAP EPS midpoint.
- September 30, 2026 investor day and any new long-term financial targets.
- Evidence that Multiphysics Fusion moves from evaluation to paid fiscal 2027 revenue.
- Processor IP Solutions divestiture closing and clarity on post-divestiture Design IP growth.
Monitoring Items
- Design Automation organic growth excluding Ansys channel-accounting impact.
- Design IP sequential growth, win rates, and new hyperscaler contract structures.
- RPO/backlog quality and renewal commentary.
- Free cash flow, debt paydown, interest expense, and share repurchases.
Risks
- Ansys integration: revenue synergy, channel integration, product integration, and cost synergy must happen while core EDA execution stays strong.
- Export controls: restrictions on advanced design tools can pressure China revenue and design starts.
- Customer concentration: hyperscaler and leading semiconductor demand is a strength, but it can concentrate renewal, pricing, and project timing risk.
- IP cyclicality: Design IP can be lumpy and customer-specific, and Q2 still showed year-over-year weakness.
- Valuation compression: if growth normalizes toward low-double-digit software growth while the multiple stays above most software peers, downside can come from the multiple even if fundamentals remain solid.
Evidence Confidence, Assumptions, Conflicts, And Open Work
Evidence Confidence
Medium-high for reported financials, guidance, estimates, market data, and source availability. Confidence is lower for organic growth excluding Ansys, product-level revenue synergies, customer concentration, and product-line margins because those are not fully disclosed.
Major Assumptions
- United States dollars are the source currency, so no exchange rate conversion was required.
- Fiscal quarter labels were normalized by period-end date because Fiscal.ai estimate labels use calendar quarter conventions.
- FY26 Q3 uses company-guided midpoint; FY26 Q4 through FY27 Q2 use Fiscal.ai consensus mean estimates.
- Valuation context uses a live Yahoo Finance price and Fiscal.ai shares, debt, and cash values.
Source Conflicts
- Live Yahoo price and Fiscal.ai market capitalization differ modestly because they were observed at different intraday times.
- GAAP and non-GAAP earnings tell very different stories while acquisition amortization and restructuring charges remain elevated.
- Company guidance includes Ansys channel-accounting impact, expected divestitures, and acquisition contribution, so headline growth is not clean organic growth.
Open Evidence Requests
- Synopsys organic revenue growth by core EDA, legacy Ansys, and Design IP.
- Customer-level exposure to hyperscalers and leading AI chip programs.
- Pricing model evidence for agentic EDA and Multiphysics Fusion.
- Debt maturity schedule, deleveraging plan, and normalized GAAP earnings bridge after integration charges decline.